Humatica advises the Riverside Company on their recent investment in E&A Scheer, a European rum brand

ndetails

Humatica Ltd. was retained to advise the Riverside Company on its significant investment in E&A Scheer (Scheer), the largest global blender and vendor of premium rum in bulk. With origins dating back to 1712, Scheer specializes in sourcing and custom-blending to create high-quality, tailor-made rum blends. Scheer’s blending operation is located in Amsterdam, Netherlands, and aging facilities reside in Liverpool, United Kingdom, where its subsidiary the Main Rum Company (MRC) is located.

Humatica provided organisational due diligence services for this transaction.

To view the Press release: Humatica advises the Riverside Company on their recent investment in E&A Scheer

Related News

Humatica Delivers Continued Growth in 1H 2025 and Wins Top Industry Honors
10 Jul, 2025 By Humatica

Humatica Delivers Continued Growth in 1H 2025 and Wins Top Industry Honors

Zurich, 10 July 2025 – Humatica posted further growth in the first half of 2025, topping record same-period growth last year. Consulting fee revenues increased…

Read more arrowicon
GloCoach & Humatica partner to deliver the most powerful AI-enabled solution to improve organizational effectiveness
09 Jul, 2025 By Humatica

GloCoach & Humatica partner to deliver the most powerful AI-enabled solution to improve organizational effectiveness

Accelerating behavioral change to improve business performance GloCoach, the global leader in AI-enabled leadership development and coaching, and Humatica, the leading advisor in organizational effectiveness…

Read more arrowicon
Humatica Wins RealDeals Private Equity Award for Value Creation Adviser of the Year for a Second Time since 2023
14 Apr, 2025 By Humatica

Humatica Wins RealDeals Private Equity Award for Value Creation Adviser of the Year for a Second Time since 2023

Humatica, the leading specialist advisor to private equity firms on organizational effectiveness, is proud to announce that it has been named Value Creation Adviser of…

Read more arrowicon